Ra Capital Management, L.P. 4 D Molecular Therapeutics, Inc. Call Options Transaction History
Ra Capital Management, L.P.
- $6.64 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding FDMT
# of Institutions
152Shares Held
57.3MCall Options Held
55.6KPut Options Held
167K-
Black Rock Inc. New York, NY4.9MShares$39.8 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY4.4MShares$35.7 Million10.13% of portfolio
-
Goldman Sachs Group Inc New York, NY4.13MShares$33.6 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.06MShares$33 Million2.8% of portfolio
-
Bvf Inc San Francisco, CA3.92MShares$31.8 Million2.52% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $263M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...